Detalhe da pesquisa
1.
Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches.
Heart Fail Rev
; 26(1): 11-21, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783110
2.
Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure).
Biomarkers
; 25(2): 201-211, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32063068
3.
NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Circulation
; 137(16): 1671-1683, 2018 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242350
4.
Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
Am Heart J
; 170(3): 531-42.e1, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26385037
5.
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
J Card Fail
; 21(11): 930-4, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216495
6.
Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)".
Circulation
; 138(17): 1910-1911, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30354664
7.
Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
Am Heart J
; 168(1): 30-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24952857
8.
Digital consults to optimize guideline-directed therapy: design of a pragmatic multicenter randomized controlled trial.
ESC Heart Fail
; 11(1): 560-569, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146630
9.
Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
Int J Cardiol
; 332: 35-37, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676945
10.
Response to: Letter to the editor regarding the manuscript "Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-ProBNP target on the reduction of readmission and Mortality rAtes".
Am Heart J
; 169(4): e5, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819869
11.
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials.
Clin Res Cardiol
; 109(2): 194-204, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31250134
12.
Estimating the Lifetime Benefits of Treatments for Heart Failure.
JACC Heart Fail
; 8(12): 984-995, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039448
13.
Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure.
ESC Heart Fail
; 7(3): 953-963, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167681
14.
Sex differences in circulating proteins in heart failure with preserved ejection fraction.
Biol Sex Differ
; 11(1): 47, 2020 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32831121
15.
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
Heart
; 105(15): 1182-1189, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962192
16.
Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative.
Clin Res Cardiol
; 108(11): 1215-1225, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953180
17.
External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure.
J Am Heart Assoc
; 8(14): e010309, 2019 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31296084
18.
Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
JACC Heart Fail
; 4(9): 736-45, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27395353
19.
Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure.
Eur J Heart Fail
; 22(5): 901-903, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243646
20.
Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
Eur J Heart Fail
; 17(9): 936-44, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26222618